BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Afraxis, Inc. 

11099 N Torrey Pines Rd
Suite 100
La Jolla``  California  11099  U.S.A.
Phone: 858-768-7823 Fax: 858-200-0821


SEARCH JOBS




Industry
Biotechnology

Segment
Biotechnology





 Company News
Sunovion Pharmaceuticals Inc. and Afraxis, Inc. Announce Novel Drug Discovery Partnership 8/13/2013 10:07:38 AM    More...
Afraxis, Inc. and Servier Announce a Collaboration on ESP Platform for Drug Discovery in Central Nervous System Disorders 4/30/2013 10:37:38 AM    More...
Afraxis, Inc. Appoints Carmine Stengone President and CEO 4/29/2013 8:36:12 AM    More...
Genentech (RHHBY) Grabs Afraxis, Inc. Compound Rights for Up to $187.5 Million 1/29/2013 6:59:58 AM    More...
Afraxis, Inc. and PsychoGenics Inc. Form Alliance to Offer Afraxis’ ESP Technology for Drug Discovery 7/16/2012 10:36:22 AM    More...
Afraxis, Inc. and PsychoGenics Inc. Form Alliance to Offer Afraxis' ESP Technology for Drug Discovery 7/16/2012 10:20:26 AM    More...
Afraxis, Inc. Enters Collaboration with National Institutes of Health (NIH) as Part of Therapeutics for Rare and Neglected Disease Program 9/26/2011 11:31:34 AM    More...